Maximum Daily Dose of Paracetamol
For adults, the maximum daily dose of paracetamol is 4000 mg (4 grams) per day, not exceeding 1000 mg per dose every 4-6 hours, with a maximum of 6 doses in 24 hours 1.
Adult Dosing
The FDA-approved dosing for adults and children ≥12 years is:
- Standard dose: 650 mg (20.3 mL liquid) every 4-6 hours
- Maximum: 6 doses per 24 hours
- Absolute daily limit: 4000 mg 1
This 4 g/day maximum is supported by research demonstrating adequate analgesic efficacy with an optimal unit dose of 1 g in adults, with effects lasting approximately 6 hours 2. The evidence consistently shows this dosing provides therapeutic benefit while minimizing hepatotoxicity risk in the general population 3.
Pediatric Dosing
For children, dosing is weight-based and age-banded 1:
- Ages 6-12 years: 325 mg every 4 hours (max 5 doses/24 hours)
- Ages 4-6 years: 240 mg every 4 hours (max 5 doses/24 hours)
- Ages 2-4 years: 160 mg every 4 hours (max 5 doses/24 hours)
- Under 2 years: Consult physician
Weight-based calculation: 15 mg/kg every 4 hours, with a maximum of 60-75 mg/kg/day 2, 4. Recent BNF-C guidelines recommend 75 mg/kg/day maximum for post-operative pain, though some institutions use 80 mg/kg/day for acute severe pain 4.
High-Risk Populations Requiring Dose Reduction
Patients with Liver Disease
Paracetamol is contraindicated in hepatic insufficiency 1, 2. For patients with chronic, stable liver disease requiring longer-term use, dose reduction is recommended, though specific thresholds are not definitively established 5. Recent evidence from Hong Kong suggests a reduced maximum of ≤3 g/day for susceptible patients with liver function monitoring 6.
Chronic Alcohol Users
This remains the most controversial area. The FDA label warns patients consuming ≥3 alcoholic drinks daily to consult a physician before use 1. However, the evidence is conflicting:
Against dose reduction: A Class I randomized controlled trial found no increase in liver toxicity among alcoholic patients given the full 4 g/day therapeutic dose, with no statistically significant difference in liver function tests compared to placebo 7. The 2007 guideline notes that "a Class I study and 2 Class III studies found no evidence to support" that chronic alcohol abuse predisposes to hepatotoxicity at therapeutic doses 8.
Supporting caution: Recent case reports (2024-2025) demonstrate severe hepatotoxicity and death in chronic alcohol users taking "therapeutic" doses, with atypical presentations including severe lactic acidosis 9. A 2026 animal study showed subchronic alcohol exposure significantly exacerbated APAP-induced liver injury through macrophage-mediated inflammation and mitochondrial dysfunction 10.
Clinical recommendation: Given the recent high-quality case evidence of mortality at therapeutic doses in alcoholics 9, and the biological plausibility of enhanced toxicity 10, limit paracetamol to ≤3 g/day in chronic alcohol users despite older evidence suggesting safety at 4 g/day. Monitor liver function if use exceeds 2-3 days.
Additional Risk Factors for Dose Reduction
Based on 2024 Hong Kong data identifying risk factors for hepatotoxicity at normal therapeutic doses 6:
- Age >80 years
- Body weight <50 kg
- Malnutrition
- Duration >2 days at doses >3 g/day
For these patients, reduce maximum to 3 g/day with liver function monitoring.
Critical Warnings on Supratherapeutic Dosing
Repeated supratherapeutic ingestions (doses >4 g/day) carry significant mortality risk. Evidence shows hepatotoxicity, hepatic failure, and death at doses ranging from just over 4 g/day to >15 g/day 8. In one prospective study, patients taking mean doses of 12-12.6 g/day over 72 hours had mortality rates of 2-14% 8.
The liver warning is absolute: Severe liver damage may occur if an adult takes more than 6 doses in 24 hours or >4000 mg total 1.
Practical Pitfalls to Avoid
- Combination products: Many over-the-counter medications contain paracetamol. Always verify total daily intake from all sources 1.
- Extended-release formulations: Limited data exists; absorption is prolonged, requiring individualized treatment decisions 8.
- Viral hepatitis patients: Concurrent paracetamol use in acute viral hepatitis may worsen outcomes, with one study showing 51.6% mortality in high-exposure groups 11. Use extreme caution or avoid in acute viral hepatitis.